Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bahaa Mustafa

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOP | Pharmaceutical Science
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0000-0002-3306-6140 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse Affiliation 
    Collapse member of
    American Peptide Society
    American Association of Cancer Research

    Collapse Biography 
    Collapse Leadership and Administrative Roles
    Curriculum committee
    Admission committee

    Collapse education and training
    University of Missouri-Kansas City, Kansas CityPhD05/2022Pharmaceutical Sciences
    Petra University, JordanMasters07/2015Pharmaceutical Sciences
    Applied Science University, JordanBachelor01/2010Pharmacy
    Collapse awards and honors
    2017 - 2021Fulbright Scholarship award, Department of state
    2022Best seminar speaker award, University of Missouri-Kansas City
    2022Preparing Future Faculty award, University of Missouri-Kansas City
    2018 - 2020Outstanding leadership award, University of Missouri-Kansas City

    Collapse Teaching 
    Collapse teaching overview
    Course instructor for Pharmaceutics I course
    Course instructor for Pharmacology I course


    Collapse Research 
    Collapse research overview
    A researcher with 5 years of cancer immunotherapy, biotherapeutics discovery, and nanomedicine experience. Successfully discovered peptide-based checkpoint inhibitors for cancer immunotherapy as well as established ELISA assay to screen innate immune checkpoint inhibitors. My strongest laboratory skills include molecular biology techniques, In-vivo studies, ELISA, cell-based assays, peptide phage display, SPR, and fluorescence microscopy.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Ferdous KU, Tesfay MZ, Cios A, Shelton RS, Hartupee C, Urbaniak A, Chamcheu JC, Mavros MN, Giorgakis E, Mustafa B, Simoes CC, Miousse IR, Basnakian AG, Moaven O, Post SR, Cannon MJ, Kelly T, Nagalo BM. Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines. 2024 Jul 18; 12(7). PMID: 39062169.
      View in: PubMed
    2. Mustafa B, Fetse J, Kandel S, Lin CY, Adhikary P, Mamani UF, Liu Y, Ibrahim MN, Alahmari M, Cheng K. Discovery of Anti-CD47 Peptides as Innate Immune Checkpoint Inhibitors. Adv Ther (Weinh). 2023 Dec; 6(12). PMID: 38655206.
      View in: PubMed
    3. Fetse J, Zhao Z, Liu H, Mamani UF, Mustafa B, Adhikary P, Ibrahim M, Liu Y, Patel P, Nakhjiri M, Alahmari M, Li G, Cheng K. Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy. J Med Chem. 2022 09 22; 65(18):12002-12013. PMID: 36067356.
      View in: PubMed
    4. Liu H, Liu Y, Zhao Z, Li Y, Mustafa B, Chen Z, Barve A, Jain A, Yao X, Li G, Cheng K. Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Front Immunol. 2022; 13:838966. PMID: 35444660.
      View in: PubMed
    5. Adhikary P, Kandel S, Mamani UF, Mustafa B, Hao S, Qiu J, Fetse J, Liu Y, Ibrahim NM, Li Y, Lin CY, Omoscharka E, Cheng K. Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity. Adv Ther (Weinh). 2021 Jul; 4(7):2100087. PMID: 34179347.
      View in: PubMed
    Mustafa's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description